{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:31:45Z","timestamp":1792009905374,"version":"4.4.0"},"reference-count":45,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Nantong University Special Research Fund for Clinical Medicine","award":["2024LQ034"],"award-info":[{"award-number":["2024LQ034"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300730"],"award-info":[{"award-number":["82300730"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500707"],"award-info":[{"award-number":["82500707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Changzhou Science and Technology Bureau of China","award":["CJ20241116"],"award-info":[{"award-number":["CJ20241116"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the potential role of the environmental pollutant tris(2-butoxyethyl) phosphate (TBOEP) in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) and to elucidate its underlying molecular mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We employed an integrated multi-omics approach. First, a multidatabase strategy identified overlapping targets between TBOEP and MASLD, which were subjected to functional enrichment and protein\u2013protein interaction (PPI) network analysis. Molecular docking was then used to predict binding affinities. Second, transcriptomic profiling (RNA sequencing (RNA-seq)) was performed on TBOEP-treated AML-12 hepatocytes to identify differentially expressed genes and pathways. Finally, key findings were validated in vitro using Oil Red O staining, triglyceride quantification and western blot analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 154 common targets between TBOEP and MASLD, with enrichment analysis pointing to pathways in non-alcoholic fatty liver disease and insulin resistance. PPI analysis highlighted ACTB, IL6, PPARG and PPARA as pivotal hub proteins. RNA-seq revealed 326 differentially expressed genes, with significant alterations in metabolic pathways. Cross-referencing pathways predicted from target genes with RNA-seq data revealed 10 pathways potentially impacted by TBOEP, emphasising its multifaceted effects on hepatocyte function. In vitro studies showed that TBOEP promotes lipid accumulation in hepatocytes by increasing PPAR\u03b3 expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study provides evidence that TBOEP acts as a potential environmental risk factor for MASLD. We demonstrate that TBOEP promotes hepatocyte steatosis, likely through the dysregulation of metabolic pathways centred on PPAR\u03b3 signalling. These findings provide new insights into the pathogenesis of MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2025-002123","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:55:14Z","timestamp":1772546114000},"page":"e002123","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Using an integrative multi-omics and in vitro approach to investigate the role of tris(2-butoxyethyl) phosphate in promoting hepatic steatosis"],"prefix":"10.1136","volume":"13","author":[{"given":"Gang","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rheumatology and Immunology, Changzhou Children\u2019s Hospital of Nantong University, Changzhou, China"},{"name":"Department of General Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Department, Jiamusi Tuberculosis Hospital, Jiamusi, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1035-4895","authenticated-orcid":false,"given":"Hanyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, China"},{"name":"Department of Hepatology and Gastroenterology, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Campus Virchow\u2011Klinikum and Campus Charit\u00e9 Mitte, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5130-4309","authenticated-orcid":false,"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology and Immunology, Changzhou Children\u2019s Hospital of Nantong University, Changzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2026030305550842000_13.1.e002123.1","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions","volume":"21","author":"Mak","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026030305550842000_13.1.e002123.2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur J Intern Med"},{"key":"2026030305550842000_13.1.e002123.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001404","article-title":"Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD","volume":"11","author":"Schreiner","year":"2024","journal-title":"BMJ Open Gastroenterol"},{"key":"2026030305550842000_13.1.e002123.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001670","article-title":"eHealth interventions and patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"12","author":"Zafar","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"key":"2026030305550842000_13.1.e002123.5","doi-asserted-by":"crossref","unstructured":"Liu H , Lefere S , Guillot A , et al . Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): Current knowledge of mechanisms. Hepatology 2025. doi:10.1097\/HEP.0000000000001417","DOI":"10.1097\/HEP.0000000000001417"},{"key":"2026030305550842000_13.1.e002123.6","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100196","article-title":"Key takeaways from the updated multidisciplinary European MASLD guidelines","volume":"3","author":"Horn","year":"2025","journal-title":"egastro"},{"key":"2026030305550842000_13.1.e002123.7","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/liv.15845","article-title":"Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus","volume":"44","author":"Lavrado","year":"2024","journal-title":"Liver Int"},{"key":"2026030305550842000_13.1.e002123.8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3350\/cmh.2024.0268","article-title":"TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD","volume":"30","author":"Sun","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"2026030305550842000_13.1.e002123.9","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100204","article-title":"Gut dysbiosis is linked to severe steatosis and enhances its diagnostic performance in MASLD","volume":"3","author":"Borges-Canha","year":"2025","journal-title":"egastro"},{"key":"2026030305550842000_13.1.e002123.10","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0431"},{"key":"2026030305550842000_13.1.e002123.11","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05165-z"},{"key":"2026030305550842000_13.1.e002123.12","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100063","article-title":"Environmental PM 2.5 -triggered stress responses in digestive diseases","volume":"2","author":"Zhang","year":"2024","journal-title":"Egastro"},{"key":"2026030305550842000_13.1.e002123.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2012.03.067"},{"key":"2026030305550842000_13.1.e002123.14","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquatox.2023.106401","article-title":"The growth toxicity and neurotoxicity mechanism of waterborne TBOEP to nematodes: Insights from transcriptomic and metabolomic profiles","volume":"256","author":"Ju","year":"2023","journal-title":"Aquat Toxicol"},{"key":"2026030305550842000_13.1.e002123.15","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1021\/acs.est.8b00727","article-title":"Occurrence and Distribution of Organophosphate Flame Retardants\/Plasticizers in Surface Waters, Tap Water, and Rainwater: Implications for Human Exposure","volume":"52","author":"Kim","year":"2018","journal-title":"Environ Sci Technol"},{"key":"2026030305550842000_13.1.e002123.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115696","article-title":"Organophosphorus flame retardants and their metabolites in paired human blood and urine","volume":"268","author":"Guo","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"2026030305550842000_13.1.e002123.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquatox.2016.11.019"},{"key":"2026030305550842000_13.1.e002123.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0668.2009.00629.x"},{"key":"2026030305550842000_13.1.e002123.19","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.chemosphere.2015.10.049","article-title":"Effects of tris (2-butoxyethyl) phosphate (TBOEP) on endocrine axes during development of early life stages of zebrafish (Danio rerio)","volume":"144","author":"Ma","year":"2016","journal-title":"Chemosphere"},{"key":"2026030305550842000_13.1.e002123.20","doi-asserted-by":"crossref","first-page":"17532","DOI":"10.1021\/acs.est.4c04180","article-title":"Identification of Primary Organophosphate Esters Contributing to Enhanced Risk of Gestational Diabetes Mellitus Based on a Case-Control Study","volume":"58","author":"Deng","year":"2024","journal-title":"Environ Sci Technol"},{"key":"2026030305550842000_13.1.e002123.21","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107209","article-title":"Alkyl organophosphate flame retardants (OPFRs) induce lung inflammation and aggravate OVA-simulated asthmatic response via the NF-\u043aB signaling pathway","volume":"163","author":"Meng","year":"2022","journal-title":"Environ Int"},{"key":"2026030305550842000_13.1.e002123.22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.aquatox.2018.03.012","article-title":"Tris (2-butoxyethyl) phosphate affects motor behavior and axonal growth in zebrafish (Danio rerio) larvae","volume":"198","author":"Jiang","year":"2018","journal-title":"Aquat Toxicol"},{"key":"2026030305550842000_13.1.e002123.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111088","article-title":"Specific human CYP enzymes-dependent mutagenicity of tris(2-butoxyethyl) phosphate (an organophosphorus flame retardant) in human and hamster cell lines","volume":"397","author":"Luo","year":"2024","journal-title":"Chem Biol Interact"},{"key":"2026030305550842000_13.1.e002123.24","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"2026030305550842000_13.1.e002123.25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3803\/EnM.2024.2281","article-title":"Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study","volume":"40","author":"Lee","year":"2025","journal-title":"Endocrinol Metab"},{"key":"2026030305550842000_13.1.e002123.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.12.002"},{"key":"2026030305550842000_13.1.e002123.27","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"key":"2026030305550842000_13.1.e002123.28","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.14218\/JCTH.2023.00334","article-title":"An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases","volume":"11","author":"Changizi","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"2026030305550842000_13.1.e002123.29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2024.09.037","article-title":"Inhibition of ATGL alleviates MASH via impaired PPAR\u03b1 signalling that favours hydrophilic bile acid composition in mice","volume":"82","author":"Dixon","year":"2025","journal-title":"J Hepatol"},{"key":"2026030305550842000_13.1.e002123.30","doi-asserted-by":"crossref","first-page":"106786","DOI":"10.1016\/j.phrs.2023.106786","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)","volume":"192","author":"Qiu","year":"2023","journal-title":"Pharmacol Res"},{"key":"2026030305550842000_13.1.e002123.31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108391","article-title":"PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets","volume":"245","author":"Chen","year":"2023","journal-title":"Pharmacol Ther"},{"key":"2026030305550842000_13.1.e002123.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2036205"},{"key":"2026030305550842000_13.1.e002123.33","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007154"},{"key":"2026030305550842000_13.1.e002123.34","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13120"},{"key":"2026030305550842000_13.1.e002123.35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41401-020-00534-y","article-title":"Ursolic acid reduces hepatocellular apoptosis and alleviates alcohol-induced liver injury via irreversible inhibition of CASP3 in vivo","volume":"42","author":"Ma","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"2026030305550842000_13.1.e002123.36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41574-024-01037-0","article-title":"Liver-specific actions of GH and IGF1 that protect against MASLD","volume":"21","author":"Kineman","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"2026030305550842000_13.1.e002123.37","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12121221","article-title":"The Role of the GH\/IGF1 Axis on the Development of MAFLD in Pediatric Patients with Obesity","volume":"12","author":"Mosca","year":"2022","journal-title":"Metabolites"},{"key":"2026030305550842000_13.1.e002123.38","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac088"},{"key":"2026030305550842000_13.1.e002123.39","doi-asserted-by":"publisher","DOI":"10.1021\/tx700079z"},{"key":"2026030305550842000_13.1.e002123.40","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21902","article-title":"Detoxification of benzo[a]pyrene primarily depends on cytochrome P450, while bioactivation involves additional oxidoreductases including 5\u2010lipoxygenase, cyclooxygenase, and aldo\u2010keto reductase in the liver","volume":"31","author":"Wang","year":"2017","journal-title":"J Biochem & Molecular Tox"},{"key":"2026030305550842000_13.1.e002123.41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 Enzymes and Drug Metabolism in Humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026030305550842000_13.1.e002123.42","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2025.179211","article-title":"Toxicological insights into graphene family materials: Cytochrome P450 modulation and cellular stress in liver cells","volume":"974","author":"Strojny-Cie\u015blak","year":"2025","journal-title":"Sci Total Environ"},{"key":"2026030305550842000_13.1.e002123.43","doi-asserted-by":"crossref","DOI":"10.3390\/cells13231958","article-title":"Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review","volume":"13","author":"Mokhosoev","year":"2024","journal-title":"Cells"},{"key":"2026030305550842000_13.1.e002123.44","doi-asserted-by":"crossref","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026030305550842000_13.1.e002123.45","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"BMJ"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2025-002123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:55:23Z","timestamp":1772546123000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2025-002123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,3]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjgast-2025-002123"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2025-002123","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}